サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1643304

動物用感染症診断市場- 世界の産業規模、シェア、動向、機会、予測、セグメント、技術別、動物タイプ別、エンドユーザー別、地域別、競合、2020年～2030年

Veterinary Infectious Disease Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technology, By Animal Type, By End User, By Region and Competition, 2020-2030F

出版日
ページ情報
英文 187 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円

こちらのレポートには、数時間（ご購入金額の10%）分のアナリストへの質問／追加調査サービスが含まれております。

動物用感染症診断市場- 世界の産業規模、シェア、動向、機会、予測、セグメント、技術別、動物タイプ別、エンドユーザー別、地域別、競合、2020年～2030年
出版日: 2025年01月24日
発行: TechSci Research
ページ情報: 英文 187 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

動物用感染症診断の世界市場規模は2024年に15億2,000万米ドルで、予測期間中のCAGRは5.25%で2030年には20億4,000万米ドルに達すると予測されています。

世界の獣医業界は、動物の予防ヘルスケアと診断に重点を置くようになり、パラダイムシフトを経験しています。人畜共通感染症への懸念や家畜への感染症発生による経済的影響が高まるにつれ、先進的な動物用感染症診断への需要が高まっています。動物用感染症診断の世界市場は、この進化の最前線にあり、動物の健康を守り、食の安全を確保し、動物と人間の間の病気のトランスミッションを防ぐという重要な役割を果たしています。

市場概要
予測期間 2026-2030
市場規模：2024年 15億2,000万米ドル
市場規模：2030年 20億4,000万米ドル
CAGR：2025年～2030年 5.25%
急成長セグメント 分子診断
最大市場 北米

人獣共通感染症の増加により、動物と人間の健康は相互に関連しているという認識が高まっています。鳥インフルエンザ、ブルセラ症、レプトスピラ症などの疾病は動物と人間の間で感染する可能性があり、強固な診断ツールの必要性が強調されています。PCR（ポリメラーゼ連鎖反応）や次世代シーケンシングなどの診断技術の進歩は、動物用感染症診断の精度とスピードに革命をもたらしました。これらの技術は、病原体の早期発見と正確な同定を可能にします。ペットを飼う傾向が強まるにつれ、診断を含む獣医学サービスへの需要が高まっています。ペットの飼い主が動物の予防ヘルスケアに投資する傾向が強まっており、高度な診断検査への需要が高まっています。畜産業の世界化に伴い、国境を越えた疾病トランスミッションのリスクが高まっています。このため、規制機関や利害関係者は、動物と消費者の健康と安全を確保するため、厳格な診断プロトコルを実施するよう求められています。

市場促進要因

ペット飼育の増加とペットの人間化

人獣共通感染症の発生率の上昇

主な市場課題

診断機器の高コスト

主な市場動向

技術の進歩

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の動物用感染症診断市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • 技術別（免疫診断、分子診断、その他の獣医診断技術）
    • 動物タイプ別（ペット動物、食用動物）
    • エンドユーザー別（リファレンスラボ、獣医学研究所およびクリニック、ポイントオブケア/社内検査、調査機関および大学）
    • 地域別
    • 企業別（2024）
  • 市場マップ
    • 技術別
    • 動物タイプ別
    • エンドユーザー別
    • 地域別

第6章 北米の動物用感染症診断市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • 技術別
    • 動物タイプ別
    • エンドユーザー別
    • 国別

第7章 欧州の動物用感染症診断市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • 技術別
    • 動物タイプ別
    • エンドユーザー別
    • 国別

第8章 アジア太平洋地域の動物用感染症診断市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • 技術別
    • 動物タイプ別
    • エンドユーザー別
    • 国別

第9章 南米の動物用感染症診断市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • 技術別
    • 動物タイプ別
    • エンドユーザー別
    • 国別

第10章 中東・アフリカの動物用感染症診断市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • 技術別
    • 動物タイプ別
    • エンドユーザー別
    • 国別

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と発展

  • 最近の動向
  • 合併と買収
  • 製品上市

第13章 競合情勢

  • BIOMERIEUX
  • Heska Corporation
  • Neogen Corporation
  • INDICAL BIOSCIENCE GmbH
  • Randox Laboratories Ltd.
  • Thermo Fisher Scientific Inc.
  • Creative Diagnostics
  • DRG INSTRUMENTS GMBH
  • Chembio Diagnostic Systems, Inc.
  • Eurofins Technologies
  • Agrolabo S.p.A.
  • Abbott Laboratories inc.
  • Danaher Corporation

第14章 戦略的提言

第15章 調査会社について・免責事項

目次
Product Code: 20066

Global Veterinary Infectious Disease Diagnostics Market was valued at USD 1.52 Billion in 2024 and is expected to reach USD 2.04 Billion by 2030 with a CAGR of 5.25% during the forecast period.The global veterinary industry is experiencing a paradigm shift, with increased focus on preventive healthcare and diagnostics for animals. As concerns about zoonotic diseases and the economic impact of infectious outbreaks on livestock rise, the demand for advanced veterinary infectious disease diagnostics is growing. The Global Veterinary Infectious Disease Diagnostics Market is at the forefront of this evolution, playing a crucial role in safeguarding animal health, ensuring food safety, and preventing the transmission of diseases between animals and humans.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 1.52 Billion
Market Size 2030USD 2.04 Billion
CAGR 2025-20305.25%
Fastest Growing SegmentMolecular Diagnostics
Largest MarketNorth America

The increasing incidence of zoonotic diseases has raised awareness about the interconnectedness of animal and human health. Diseases such as avian influenza, brucellosis, and leptospirosis can be transmitted between animals and humans, emphasizing the need for robust diagnostic tools. Advances in diagnostic technologies, such as PCR (Polymerase Chain Reaction) and next-generation sequencing, have revolutionized the accuracy and speed of veterinary infectious disease diagnostics. These technologies allow for early detection and precise identification of pathogens. The growing trend of pet ownership has led to an increased demand for veterinary services, including diagnostics. Pet owners are increasingly investing in preventive healthcare for their animals, driving the demand for sophisticated diagnostic tests. With the globalization of the livestock industry, the risk of disease transmission across borders has escalated. This has prompted regulatory bodies and stakeholders to implement stringent diagnostic protocols to ensure the health and safety of animals and consumers.

Key Market Drivers

Increasing Pet Ownership and Humanization of Pets

In recent years, there has been a notable global shift in the way people perceive and care for their pets. The increasing trend of pet ownership and the growing humanization of pets have not only led to an upsurge in spending on pet healthcare but have also been significant drivers of the veterinary infectious disease diagnostics market. This market, which plays a crucial role in ensuring the health and well-being of animals, has witnessed unprecedented growth as pet owners seek advanced diagnostic solutions for their beloved companions. According to the American Veterinary Medical Association (AVMA), the number of pet-owning households has significantly increased, with dog ownership growing at a faster pace rising from 31.3 million households in 1996 to 59.8 million in 2024. In comparison, cat-owning households have also seen growth, from 27 million to 42.1 million over the same period. This surge in pet ownership, coupled with the increasing humanization of pets, is driving the global veterinary infectious disease diagnostics market, as more pet owners seek advanced medical care for their animals. The worldwide surge in pet ownership is a multifaceted phenomenon, influenced by factors such as urbanization, changing lifestyles, and an increased understanding of the emotional and physical benefits that pets bring to their owners. As more people open their homes to pets, whether they be dogs, cats, birds, or exotic animals, the demand for comprehensive veterinary care has risen significantly.

This burgeoning population of pets has given rise to a corresponding demand for advanced diagnostic tools to detect and manage infectious diseases. Veterinary infectious disease diagnostics encompass a range of tests and procedures that aid in the identification and monitoring of diseases in animals. These diagnostics not only help in the early detection of illnesses but also play a crucial role in preventing the spread of infectious diseases among animals and, in some cases, to humans.

The increasing humanization of pets is another major trend shaping the veterinary infectious disease diagnostics market. Pet owners are now more inclined to view their animals as integral members of the family, leading to a greater willingness to invest in their health and well-being. This paradigm shift has translated into higher expectations for the quality of veterinary care, including advanced diagnostics, and has fueled the growth of the global market. Pet owners are seeking not just basic veterinary services but also cutting-edge diagnostics that can provide more accurate and timely results. This shift in consumer behaviour has prompted veterinary diagnostic companies to innovate and develop new technologies and testing methods to meet the evolving demands of pet owners.

Rising Incidence of Zoonotic Diseases

Zoonotic diseases, which are infections that can be transmitted between animals and humans, have garnered increased attention in recent years due to their potential for rapid spread and devastating impact on both animal and human populations. The rise in these diseases has led to a growing demand for effective diagnostic tools, driving the expansion of the global veterinary infectious disease diagnostics market. Zoonotic diseases represent a significant public health concern, as evidenced by outbreaks such as the H1N1 influenza pandemic and the more recent COVID-19 pandemic. These diseases can originate in animals and jump to humans through various means, including direct contact, consumption of contaminated food or water, and exposure to vectors like mosquitoes and ticks. According to the Centers for Disease Control and Prevention (CDC), zoonotic diseases are widespread both in the United States and globally. Research indicates that more than 60% of known infectious diseases in humans are transmitted from animals, and approximately 75% of new or emerging infectious diseases in humans originate from animals. This growing prevalence of zoonotic diseases is fueling the demand for advanced veterinary infectious disease diagnostics, driving market growth in this sector.

The interconnectedness of animal and human health is increasingly recognized as a crucial aspect of global health. As human populations expand and encroach on natural habitats, the risk of zoonotic disease transmission escalates. Climate change, international travel, and the global movement of goods further contribute to the complexity of disease transmission dynamics. Efficient and accurate diagnostics play a pivotal role in preventing, controlling, and managing zoonotic diseases. In response to the rising threat, the global veterinary infectious disease diagnostics market has witnessed substantial growth. Diagnostic techniques include traditional methods such as serological testing and microbial culture, as well as advanced molecular techniques like polymerase chain reaction (PCR) and next-generation sequencing.

Key Market Challenges

High Cost of Diagnostic Equipment

The field of veterinary diagnostics plays a crucial role in safeguarding the health of animals and preventing the spread of infectious diseases. As technology continues to advance, the demand for accurate and timely diagnostics in the veterinary sector has grown exponentially. However, one formidable challenge hindering the progress of the Global Veterinary Infectious Disease Diagnostics Market is the exorbitant cost associated with diagnostic equipment. The high cost of diagnostic equipment limits access to advanced veterinary diagnostics, especially in developing regions. Rural areas, where agriculture is a significant part of the economy, often lack access to state-of-the-art diagnostic tools. This limited accessibility can impede early detection and timely intervention, allowing infectious diseases to spread unchecked.

Veterinary clinics and laboratories, facing the burden of expensive diagnostic equipment, may struggle to invest in the latest technologies. The financial strain on these establishments not only affects their ability to provide cutting-edge services but also impacts their competitiveness in the market. High equipment costs can also hinder research and development efforts in veterinary diagnostics. Smaller companies and research institutions may find it challenging to invest in innovative technologies, slowing down progress in the field and limiting the development of new diagnostic methods. The cost of diagnostic services is inevitably passed on to pet owners and livestock farmers. This can deter individuals from seeking early diagnostic testing for their animals, leading to delayed disease detection and increased treatment costs in the long run.

Key Market Trends

Technological Advancements

In recent years, the global veterinary industry has experienced a significant transformation, with a sharp focus on technological advancements to address the challenges posed by infectious diseases in animals. The Veterinary Infectious Disease Diagnostics Market has witnessed a remarkable surge, driven by cutting-edge technologies that are revolutionizing the way diseases are diagnosed and treated in animals. One of the primary drivers of the veterinary infectious disease diagnostics market is the continuous evolution of diagnostic technologies. Traditional methods are being replaced or complemented by more sophisticated and rapid techniques. Molecular diagnostics, next-generation sequencing, and advanced imaging technologies have become instrumental in providing quick and accurate diagnoses. These technologies not only enhance the speed of diagnosis but also improve the precision and reliability of results.

Segmental Insights

Technology Insights

Based on technology, Molecular Diagnostics emerged as the fastest growing segment in the global market for Veterinary Infectious Disease Diagnostics during the forecast period. Molecular diagnostic methods, including techniques like Polymerase Chain Reaction (PCR), enable the detection of pathogens at the genetic level, offering greater accuracy and sensitivity compared to traditional diagnostic approaches. This enhanced precision is essential for the early identification of infectious diseases, which leads to improved animal health outcomes. Furthermore, molecular diagnostics are highly effective in detecting emerging or novel pathogens that may be difficult to identify using conventional methods. This is particularly important in managing evolving infectious disease risks, including zoonotic diseases that can impact both animals and humans. Advancements in molecular technologies, such as miniaturization and automation, have also made these diagnostic tools more affordable and accessible to veterinary clinics and research institutions, driving their widespread adoption.

Animal Type Insights

Based on Animal Type, the companion animals emerged as the dominating segment in the global market for Veterinary Infectious Disease Diagnostics in 2024. As pets are increasingly regarded as family members, there is a stronger focus on providing them with premium care. Pet owners are more inclined to invest in veterinary services, including diagnostic tests, to ensure their pets' health and well-being. This shift in mindset is driving the demand for advanced diagnostic technologies for companion animals. Additionally, the rising number of pet-owning households, particularly those with dogs and cats, is fueling the need for veterinary care. As the pet population grows, the demand for diagnostics to detect and manage infectious diseases also increases. Pet owners are becoming more proactive about their pets' health, seeking early diagnoses and preventive care to enhance their pets' longevity and quality of life. This growing awareness has led to a greater reliance on diagnostics for early detection of infectious diseases, such as viral, bacterial, and parasitic infections. Furthermore, the expanding market for pet pharmaceuticals, vaccinations, and healthcare products further supports the need for diagnostic testing, with veterinary clinics and hospitals increasingly depending on these tools to guide treatment and improve care.

Regional Insights

Based on Region, North America emerged as the dominant region in the Global Veterinary Infectious Disease Diagnostics Market in 2024. North America, particularly the United States, boasts one of the highest rates of pet ownership globally, with a substantial proportion of households owning dogs, cats, and other pets. As of 2024, 66% of U.S. households have a pet, equating to approximately 86.9 million families. This growing pet population drives the increased demand for veterinary services, including diagnostic testing. The rising trend of treating pets as family members in North America is leading to a greater emphasis on high-quality, advanced care, thus driving the need for sophisticated diagnostic tools to maintain pet health and well-being. According to the American Pet Products Association (APPA), U.S. pet-related expenditures reached 147 billion in 2023. North America also has well-established veterinary healthcare infrastructure with access to cutting-edge diagnostic technologies. Veterinary clinics and hospitals in the region are equipped with state-of-the-art tools for detecting infectious diseases in animals, reinforcing the region's dominance in the market. Furthermore, North American pet owners are more inclined to invest in veterinary services, including diagnostics, treatments, and preventive care, which has significantly contributed to the market's growth. The widespread availability of pet health information through veterinary organizations, pet health websites, and media outlets has heightened awareness of the importance of diagnostics for infectious diseases, leading to greater adoption of advanced diagnostic methods. These factors collectively create a favorable environment for the continued growth of the veterinary infectious disease diagnostics market, solidifying North America's leadership in the industry.

Key Market Players

  • BIOMERIEUX
  • Heska Corporation
  • Neogen Corporation
  • INDICAL BIOSCIENCE GmbH
  • Randox Laboratories Ltd.
  • Thermo Fisher Scientific Inc.
  • Creative Diagnostics
  • DRG INSTRUMENTS GMBH
  • Chembio Diagnostic Systems, Inc.
  • Eurofins Technologies
  • Agrolabo S.p.A.
  • Abbott Laboratories inc.
  • Danaher Corporation

Report Scope:

In this report, the Global Veterinary Infectious Disease Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Veterinary Infectious Disease Diagnostics Market, By Product:

  • Immunodiagnostics
  • Molecular Diagnostics
  • Other Veterinary Diagnostic Technologies

Veterinary Infectious Disease Diagnostics Market, By Animal Type :

  • Companion Animals
  • Food Producing Animals

Veterinary Infectious Disease Diagnostics Market, By End user:

  • Reference Laboratories
  • Veterinary Laboratories and Clinics
  • Point of Care / In House Testing
  • Research Institutes and Universities

Veterinary Infectious Disease Diagnostics Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Veterinary Infectious Disease Diagnostics Market.

Available Customizations:

Global Veterinary Infectious Disease Diagnostics market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Veterinary Infectious Disease Diagnostics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Technology (Immunodiagnostics, Molecular Diagnostics, Other Veterinary Diagnostic Technologies)
    • 5.2.2. By Animal Type (Companion Animals, Food Producing Animals)
    • 5.2.3. By End User (Reference Laboratories, Veterinary Laboratories and Clinics, Point of Care / In House Testing, Research Institutes and Universities)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Market Map
    • 5.3.1. By Technology
    • 5.3.2. By Animal Type
    • 5.3.3. By End User
    • 5.3.4. By Region

6. North America Veterinary Infectious Disease Diagnostics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Technology
    • 6.2.2. By Animal Type
    • 6.2.3. By End User
    • 6.2.4. By Country
      • 6.2.4.1. United States Veterinary Infectious Disease Diagnostics Market Outlook
        • 6.2.4.1.1. Market Size & Forecast
        • 6.2.4.1.1.1. By Value
        • 6.2.4.1.2. Market Share & Forecast
        • 6.2.4.1.2.1. By Technology
        • 6.2.4.1.2.2. By Animal Type
        • 6.2.4.1.2.3. By End User
      • 6.2.4.2. Canada Veterinary Infectious Disease Diagnostics Market Outlook
        • 6.2.4.2.1. Market Size & Forecast
        • 6.2.4.2.1.1. By Value
        • 6.2.4.2.2. Market Share & Forecast
        • 6.2.4.2.2.1. By Technology
        • 6.2.4.2.2.2. By Animal Type
        • 6.2.4.2.2.3. By End User
      • 6.2.4.3. Mexico Veterinary Infectious Disease Diagnostics Market Outlook
        • 6.2.4.3.1. Market Size & Forecast
        • 6.2.4.3.1.1. By Value
        • 6.2.4.3.2. Market Share & Forecast
        • 6.2.4.3.2.1. By Technology
        • 6.2.4.3.2.2. By Animal Type
        • 6.2.4.3.2.3. By End User

7. Europe Veterinary Infectious Disease Diagnostics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Technology
    • 7.2.2. By Animal Type
    • 7.2.3. By End User
    • 7.2.4. By Country
      • 7.2.4.1. France Veterinary Infectious Disease Diagnostics Market Outlook
        • 7.2.4.1.1. Market Size & Forecast
        • 7.2.4.1.1.1. By Value
        • 7.2.4.1.2. Market Share & Forecast
        • 7.2.4.1.2.1. By Technology
        • 7.2.4.1.2.2. By Animal Type
        • 7.2.4.1.2.3. By End User
      • 7.2.4.2. Germany Veterinary Infectious Disease Diagnostics Market Outlook
        • 7.2.4.2.1. Market Size & Forecast
        • 7.2.4.2.1.1. By Value
        • 7.2.4.2.2. Market Share & Forecast
        • 7.2.4.2.2.1. By Technology
        • 7.2.4.2.2.2. By Animal Type
        • 7.2.4.2.2.3. By End User
      • 7.2.4.3. United Kingdom Veterinary Infectious Disease Diagnostics Market Outlook
        • 7.2.4.3.1. Market Size & Forecast
        • 7.2.4.3.1.1. By Value
        • 7.2.4.3.2. Market Share & Forecast
        • 7.2.4.3.2.1. By Technology
        • 7.2.4.3.2.2. By Animal Type
        • 7.2.4.3.2.3. By End User
      • 7.2.4.4. Italy Veterinary Infectious Disease Diagnostics Market Outlook
        • 7.2.4.4.1. Market Size & Forecast
        • 7.2.4.4.1.1. By Value
        • 7.2.4.4.2. Market Share & Forecast
        • 7.2.4.4.2.1. By Technology
        • 7.2.4.4.2.2. By Animal Type
        • 7.2.4.4.2.3. By End User
      • 7.2.4.5. Spain Veterinary Infectious Disease Diagnostics Market Outlook
        • 7.2.4.5.1. Market Size & Forecast
        • 7.2.4.5.1.1. By Value
        • 7.2.4.5.2. Market Share & Forecast
        • 7.2.4.5.2.1. By Technology
        • 7.2.4.5.2.2. By Animal Type
        • 7.2.4.5.2.3. By End User

8. Asia Pacific Veterinary Infectious Disease Diagnostics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Technology
    • 8.2.2. By Animal Type
    • 8.2.3. By End User
    • 8.2.4. By Country
      • 8.2.4.1. China Veterinary Infectious Disease Diagnostics Market Outlook
        • 8.2.4.1.1. Market Size & Forecast
        • 8.2.4.1.1.1. By Value
        • 8.2.4.1.2. Market Share & Forecast
        • 8.2.4.1.2.1. By Technology
        • 8.2.4.1.2.2. By Animal Type
        • 8.2.4.1.2.3. By End User
      • 8.2.4.2. India Veterinary Infectious Disease Diagnostics Market Outlook
        • 8.2.4.2.1. Market Size & Forecast
        • 8.2.4.2.1.1. By Value
        • 8.2.4.2.2. Market Share & Forecast
        • 8.2.4.2.2.1. By Technology
        • 8.2.4.2.2.2. By Animal Type
        • 8.2.4.2.2.3. By End User
      • 8.2.4.3. South Korea Veterinary Infectious Disease Diagnostics Market Outlook
        • 8.2.4.3.1. Market Size & Forecast
        • 8.2.4.3.1.1. By Value
        • 8.2.4.3.2. Market Share & Forecast
        • 8.2.4.3.2.1. By Technology
        • 8.2.4.3.2.2. By Animal Type
        • 8.2.4.3.2.3. By End User
      • 8.2.4.4. Japan Veterinary Infectious Disease Diagnostics Market Outlook
        • 8.2.4.4.1. Market Size & Forecast
        • 8.2.4.4.1.1. By Value
        • 8.2.4.4.2. Market Share & Forecast
        • 8.2.4.4.2.1. By Technology
        • 8.2.4.4.2.2. By Animal Type
        • 8.2.4.4.2.3. By End User
      • 8.2.4.5. Australia Veterinary Infectious Disease Diagnostics Market Outlook
        • 8.2.4.5.1. Market Size & Forecast
        • 8.2.4.5.1.1. By Value
        • 8.2.4.5.2. Market Share & Forecast
        • 8.2.4.5.2.1. By Technology
        • 8.2.4.5.2.2. By Animal Type
        • 8.2.4.5.2.3. By End User

9. South America Veterinary Infectious Disease Diagnostics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Technology
    • 9.2.2. By Animal Type
    • 9.2.3. By End User
    • 9.2.4. By Country
      • 9.2.4.1. Brazil Veterinary Infectious Disease Diagnostics Market Outlook
        • 9.2.4.1.1. Market Size & Forecast
        • 9.2.4.1.1.1. By Value
        • 9.2.4.1.2. Market Share & Forecast
        • 9.2.4.1.2.1. By Technology
        • 9.2.4.1.2.2. By Animal Type
        • 9.2.4.1.2.3. By End User
      • 9.2.4.2. Argentina Veterinary Infectious Disease Diagnostics Market Outlook
        • 9.2.4.2.1. Market Size & Forecast
        • 9.2.4.2.1.1. By Value
        • 9.2.4.2.2. Market Share & Forecast
        • 9.2.4.2.2.1. By Technology
        • 9.2.4.2.2.2. By Animal Type
        • 9.2.4.2.2.3. By End User
      • 9.2.4.3. Colombia Veterinary Infectious Disease Diagnostics Market Outlook
        • 9.2.4.3.1. Market Size & Forecast
        • 9.2.4.3.1.1. By Value
        • 9.2.4.3.2. Market Share & Forecast
        • 9.2.4.3.2.1. By Technology
        • 9.2.4.3.2.2. By Animal Type
        • 9.2.4.3.2.3. By End User

10. Middle East & Africa Veterinary Infectious Disease Diagnostics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Technology
    • 10.2.2. By Animal Type
    • 10.2.3. By End User
    • 10.2.4. By Country
      • 10.2.4.1. South Africa Veterinary Infectious Disease Diagnostics Market Outlook
        • 10.2.4.1.1. Market Size & Forecast
        • 10.2.4.1.1.1. By Value
        • 10.2.4.1.2. Market Share & Forecast
        • 10.2.4.1.2.1. By Technology
        • 10.2.4.1.2.2. By Animal Type
        • 10.2.4.1.2.3. By End User
      • 10.2.4.2. Saudi Arabia Veterinary Infectious Disease Diagnostics Market Outlook
        • 10.2.4.2.1. Market Size & Forecast
        • 10.2.4.2.1.1. By Value
        • 10.2.4.2.2. Market Share & Forecast
        • 10.2.4.2.2.1. By Technology
        • 10.2.4.2.2.2. By Animal Type
        • 10.2.4.2.2.3. By End User
      • 10.2.4.3. UAE Veterinary Infectious Disease Diagnostics Market Outlook
        • 10.2.4.3.1. Market Size & Forecast
        • 10.2.4.3.1.1. By Value
        • 10.2.4.3.2. Market Share & Forecast
        • 10.2.4.3.2.1. By Technology
        • 10.2.4.3.2.2. By Animal Type
        • 10.2.4.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Competitive Landscape

  • 13.1. BIOMERIEUX
    • 13.1.1. Business Overview
    • 13.1.2. Patient Offerings
    • 13.1.3. Recent Developments
    • 13.1.4. Key Personnel
    • 13.1.5. SWOT Analysis
  • 13.2. Heska Corporation
  • 13.3. Neogen Corporation
  • 13.4. INDICAL BIOSCIENCE GmbH
  • 13.5. Randox Laboratories Ltd.
  • 13.6. Thermo Fisher Scientific Inc.
  • 13.7. Creative Diagnostics
  • 13.8. DRG INSTRUMENTS GMBH
  • 13.9. Chembio Diagnostic Systems, Inc.
  • 13.10.Eurofins Technologies
  • 13.11.Agrolabo S.p.A.
  • 13.12.Abbott Laboratories inc.
  • 13.13.Danaher Corporation

14. Strategic Recommendations

15. About us & Disclaimer